Founded in 2020 by industry veterans from the Pharma and Biotech industries, Salubrent is building a specialized CDMO focused exclusively on flexible batch, aseptic fill & finish drug delivery solutions.
Salubrent’s mission is to help its customers in securing our nation’s drug supply, and ensure that every American has access to the vital drugs they need, especially those that require flexible batch sizes, such as immunotherapies, orphan drugs, and personalized medicines, representing the future of disease control and prevention.
Salubrent has engineered a superior end-to-end experience for its customers. From the latest systems in customer reporting and support, to next-generation analytical testing facilities and purpose-built and self-contained production suites, Salubrent is leveraging its experience and expertise in the CDMO industry to build a workflow entirely around its customers’ needs.
By using the latest technological advances, Salubrent can reduce aseptic fill & finish manufacturing times by delivering diverse and flexible capabilities while maintaining the highest levels of quality control and assurance. Our automated robotic, closed aseptic filling systems increase quality and reduces costs by removing the need for human intervention and can fill and close multiple container types, including vials, PFS and cartridges. Changeover between two different tooling sets can be completed within one hour. With low downtime between batches, our facility effectively services both clinical and commercial stage customers.
This is made possible by our leadership team that includes some of best, brightest, and successful minds in the industry with over 200 years of experience in the CDMO, biotech and pharmaceutical industries.